FABP3 is known to interact with TNNI3K in the context of interacting with cardiac troponin I [REF].
In HIV, a synthetic peptide corresponding to the immunosuppressive domain (amino acids 574-592) of HIV-1 gp41 downregulates the expression of fatty acid binding protein 3 (FABP3) in peptide-treated PBMCs [REF].